Latest News about ENVB
Recent news which mentions ENVB
From InvestorPlace
 
   EXCLUSIVE: Enveric Biosciences Announces Non-Binding Deals To License Out Three Types of Drug Compounds
   
  
  
  February 29, 2024
  From Benzinga
 
   Enveric Biosciences Sells Cancer Patents As It Paves Way For Mental Health Treatments
   
  
  
  February 23, 2024
  From Benzinga
 
   12 Health Care Stocks Moving In Friday's Intraday Session
   
  
  
  February 23, 2024
  From Benzinga
 
   12 Health Care Stocks Moving In Friday's Pre-Market Session
   
  
  
  February 23, 2024
  From Benzinga
 
   Enveric Biosciences Deepens Its Mental Health-Focused Pipeline With Library of Preclinical Compounds
   
  
  
  February 21, 2024
  From Benzinga
 
   Psyched: Psychedelics & Sex, MDMA And Federal Approval, Canadians For End-Of-Life Care And More
   
  
  
  February 15, 2024
  From Benzinga
 
   Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More
   
  
  
  January 27, 2024
  From Benzinga
 From Benzinga
 From Benzinga
 
   Psyched: Ibogaine For TBI, Kentucky Initiative Stalled, DEA Quotas, Insurance Codes, Atai's $50M And More
   
  
  
  January 07, 2024
  From Benzinga
 
   12 Health Care Stocks Moving In Monday's Pre-Market Session
   
  
  
  January 01, 2024
  From Benzinga
 
   Why Fisker Shares Are Trading Higher By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session
   
  
  
  December 29, 2023
  From Benzinga
 
   12 Health Care Stocks Moving In Thursday's Pre-Market Session
   
  
  
  December 28, 2023
  From Benzinga
 
   Psyched: Biden Approves Psychedelics Trials, RFK, Australia's First Legal Dedicated Clinic & More
   
  
  
  December 27, 2023
  From Benzinga
 
   Psyched: Biden's Big Decision On Psychedelics Therapy; LSD Anxiety Results; Matthew Perry Autopsy And More
   
  
  
  December 18, 2023
  From Benzinga
 
   Psyched: John Lennon Remembered, Clinical Trials For Service Members, Chrissy Teigen, Jon Feliciano And More
   
  
  
  December 11, 2023
  From Benzinga
 
   Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More
   
  
  
  December 05, 2023
  From Benzinga
 
   Psyched: Ramaswamy Psychedelics For PTSD, UK Clinical Trials, Johns Hopkins Q&A And More
   
  
  
  November 24, 2023
  From Benzinga
 
   Enveric Biosciences' Revenue Drops In Q3 2023 As Next-Gen Psychedelics Advance To Clinical Trials
   
  November 14, 2023
  Tickers 
   ENVB
  
  
  From Benzinga
 
   Psyched: Veterans & Psychedelics, $100M IPO, Cybin's $64M Offering, Worldwide Events & More
   
  
  
  November 12, 2023
  From Benzinga
 
   Psyched: DEA's Denial Overruled, Fed Psychedelics Change, Psilocybin For Depression, States Reform & More
   
  
  
  November 06, 2023
  From Benzinga
 
   Psyched: Cybin's Center Stage In Novel Psychedelics, Musk & Ramaswamy, Britney's Memoirs And More
   
  
  
  October 29, 2023
  From Benzinga
 
   Psyched: Jada Pinkett-Smith's Ayahuasca Journey, RIP Dr. Roland Griffiths, Congressional VA Hearings Halted
   
  
  
  October 22, 2023
  From Benzinga
 
   Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More
   
  
  
  October 16, 2023
  From Benzinga
 
   Psyched: Steve Cohen's New Biopharma Bet, California Gov. Authorizes Medical Psychedelics & More
   
  
  
  October 06, 2023
  From Benzinga
 
   12 Health Care Stocks Moving In Wednesday's After-Market Session
   
  
  
  October 04, 2023
  From Benzinga
 
   Psyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & More
   
  
  
  October 02, 2023
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.